Home/Filings/4/0001273636-19-000006
4//SEC Filing

Feinsod Matthew 4

Accession 0001273636-19-000006

CIK 0001273636other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 6:30 PM ET

Size

6.1 KB

Accession

0001273636-19-000006

Insider Transaction Report

Form 4
Period: 2019-02-11
Feinsod Matthew
Interim Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-02-11+2,00050,078 total
  • Tax Payment

    Common Stock

    2019-02-11$3.29/sh791$2,60249,287 total
Footnotes (1)
  • [F1]The common stock vested immediately upon grant.

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeother

Related Parties

1
  • filerCIK 0001716950

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:30 PM ET
Size
6.1 KB